Brian E. Lavan

2.0k total citations
27 papers, 1.7k citations indexed

About

Brian E. Lavan is a scholar working on Molecular Biology, Surgery and Cell Biology. According to data from OpenAlex, Brian E. Lavan has authored 27 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Surgery and 4 papers in Cell Biology. Recurrent topics in Brian E. Lavan's work include Metabolism, Diabetes, and Cancer (13 papers), Pancreatic function and diabetes (9 papers) and Protein Kinase Regulation and GTPase Signaling (8 papers). Brian E. Lavan is often cited by papers focused on Metabolism, Diabetes, and Cancer (13 papers), Pancreatic function and diabetes (9 papers) and Protein Kinase Regulation and GTPase Signaling (8 papers). Brian E. Lavan collaborates with scholars based in United States, United Kingdom and Netherlands. Brian E. Lavan's co-authors include Gustav E. Lienhard, William S. Lane, Valeria R. Fantin, Susanna R. Keller, Miles D. Houslay, Ellen T. Chang, Francine M. Gregoire, Mark Bushfield, Fang Zhang and Graeme Milligan and has published in prestigious journals such as Journal of Biological Chemistry, Endocrine Reviews and Biochemical Journal.

In The Last Decade

Brian E. Lavan

27 papers receiving 1.6k citations

Peers

Brian E. Lavan
Shawn Jeffries United States
Graham J. Sale United Kingdom
Kozui Shii Japan
Kristina S. Kovacina United States
Peter A. Wilden United States
W S Lee United States
Mark C. Harbeck United States
Roger W. Hunter United Kingdom
Marc L. Goalstone United States
Tsugumichi Saito Japan
Shawn Jeffries United States
Brian E. Lavan
Citations per year, relative to Brian E. Lavan Brian E. Lavan (= 1×) peers Shawn Jeffries

Countries citing papers authored by Brian E. Lavan

Since Specialization
Citations

This map shows the geographic impact of Brian E. Lavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian E. Lavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian E. Lavan more than expected).

Fields of papers citing papers by Brian E. Lavan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian E. Lavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian E. Lavan. The network helps show where Brian E. Lavan may publish in the future.

Co-authorship network of co-authors of Brian E. Lavan

This figure shows the co-authorship network connecting the top 25 collaborators of Brian E. Lavan. A scholar is included among the top collaborators of Brian E. Lavan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian E. Lavan. Brian E. Lavan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clarke, Holly J., et al.. (2009). MBX‐102/JNJ39659100, a Novel Non‐TZD Selective Partial PPAR‐γ Agonist Lowers Triglyceride Independently of PPAR‐α Activation. PPAR Research. 2009(1). 706852–706852. 19 indexed citations
2.
Gregoire, Francine M., Fang Zhang, Holly J. Clarke, et al.. (2009). MBX-102/JNJ39659100, a Novel Peroxisome Proliferator Activated Receptor-γ Ligand with Weak Transactivation Activity Retains Full Anti-Diabetic Properties in the Absence of Side Effects. Endocrine Reviews. 30(4). 414–414. 3 indexed citations
3.
Clarke, Holly J., et al.. (2008). Cross‐Species Differential Plasma Protein Binding of MBX‐102/JNJ39659100: A Novel PPAR‐γAgonist. PPAR Research. 2008(1). 465715–465715. 14 indexed citations
4.
Zhang, Fang, Brian E. Lavan, & Francine M. Gregoire. (2007). Selective Modulators of PPAR-γActivity: Molecular Aspects Related to Obesity and Side-Effects. PPAR Research. 2007. 1–7. 98 indexed citations
5.
Zhang, Fan, et al.. (2004). Peroxisome proliferator-activated receptors as attractive antiobesity targets. Drug News & Perspectives. 17(10). 661–661. 22 indexed citations
6.
Lavan, Brian E., et al.. (2002). Rapamycin partially prevents insulin resistance induced by chronic insulin treatment. Biochemical and Biophysical Research Communications. 293(3). 1021–1027. 58 indexed citations
7.
Gustafson, Thomas A., Shonna A. Moodie, & Brian E. Lavan. (1999). The insulin receptor and metabolic signaling. PubMed. 137. 71–190. 18 indexed citations
8.
Fantin, Valeria R., et al.. (1998). Characterization of Insulin Receptor Substrate 4 in Human Embryonic Kidney 293 Cells. Journal of Biological Chemistry. 273(17). 10726–10732. 84 indexed citations
9.
Ross, Stuart A., Gustav E. Lienhard, & Brian E. Lavan. (1998). Association of Insulin Receptor Substrate 3 with SH2 Domain-Containing Proteins in Rat Adipocytes. Biochemical and Biophysical Research Communications. 247(2). 487–492. 22 indexed citations
10.
Lavan, Brian E., Valeria R. Fantin, Ellen T. Chang, et al.. (1997). A Novel 160-kDa Phosphotyrosine Protein in Insulin-treated Embryonic Kidney Cells Is a New Member of the Insulin Receptor Substrate Family. Journal of Biological Chemistry. 272(34). 21403–21407. 297 indexed citations
11.
Lavan, Brian E., William S. Lane, & Gustav E. Lienhard. (1997). The 60-kDa Phosphotyrosine Protein in Insulin-treated Adipocytes Is a New Member of the Insulin Receptor Substrate Family. Journal of Biological Chemistry. 272(17). 11439–11443. 269 indexed citations
12.
Lavan, Brian E. & Gustav E. Lienhard. (1994). Insulin signalling and the stimulation of glucose transport. Biochemical Society Transactions. 22(3). 676–680. 10 indexed citations
13.
Kuhne, Michelle, Z Zhao, Brian E. Lavan, et al.. (1994). Dephosphorylation of insulin receptor substrate 1 by the tyrosine phosphatase PTP2C.. Journal of Biological Chemistry. 269(22). 15833–15837. 70 indexed citations
14.
Keller, Susanne R., et al.. (1993). Insulin and IGF‐I signaling through the insulin receptor substrate 1. Molecular Reproduction and Development. 35(4). 346–352. 17 indexed citations
15.
Lavan, Brian E. & Gustav E. Lienhard. (1993). The insulin-elicited 60-kDa phosphotyrosine protein in rat adipocytes is associated with phosphatidylinositol 3-kinase.. Journal of Biological Chemistry. 268(8). 5921–5928. 102 indexed citations
16.
Lavan, Brian E., Michelle Kuhne, Charles W. Garner, et al.. (1992). The association of insulin-elicited phosphotyrosine proteins with src homology 2 domains.. Journal of Biological Chemistry. 267(16). 11631–11636. 94 indexed citations
17.
18.
Bushfield, Mark, Gerard J. Murphy, Brian E. Lavan, et al.. (1990). Hormonal regulation of Gi2 α-subunit phosphorylation in intact hepatocytes. Biochemical Journal. 268(2). 449–457. 104 indexed citations
19.
Lavan, Brian E., et al.. (1989). Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form. Biochemical Pharmacology. 38(22). 4123–4136. 56 indexed citations
20.
Houslay, Miles D., Nigel J. Pyne, Richard M. O’Brien, et al.. (1989). Guanine nucleotide regulatory proteins in insulin's action and in diabetes. Biochemical Society Transactions. 17(4). 627–629. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shawn Jeffries Breakdown of academic impact, for papers by Graham J. Sale Breakdown of academic impact, for papers by Kozui Shii Breakdown of academic impact, for papers by Kristina S. Kovacina Breakdown of academic impact, for papers by Peter A. Wilden Breakdown of academic impact, for papers by W S Lee Breakdown of academic impact, for papers by Mark C. Harbeck Breakdown of academic impact, for papers by Roger W. Hunter Breakdown of academic impact, for papers by Marc L. Goalstone Breakdown of academic impact, for papers by Tsugumichi Saito
Rankless by CCL
2026